Fatal attraction: tumors beckon regulatory T cells
- 1 September 2004
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 10 (9), 900-901
- https://doi.org/10.1038/nm0904-900
Abstract
Tumor tissue and ascites from patients with ovarian cancer contain high levels of cells with all the hallmarks of regulatory T cells. These cells migrate into the tumor microenvironment in a process mediated by the chemokine CCL22, and are capable of suppressing antitumor responses (pages 942–949).Keywords
This publication has 8 references indexed in Scilit:
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004
- Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands: Implications for ImmunotherapyImmunity, 2004
- Foxp3 and Natural Regulatory T CellsImmunity, 2003
- Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian CancerNew England Journal of Medicine, 2003
- Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast AdenocarcinomaPublished by The American Association of Immunologists ,2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Regulatory T Cells in AutoimmmunityAnnual Review of Immunology, 2000
- Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen NonspecificThe Journal of Immunology, 2000